Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 25;16(5):925.
doi: 10.3390/cancers16050925.

Association of Lymphovascular Invasion with Lymph Node Metastases in Prostate Cancer-Lateralization Concept

Affiliations

Association of Lymphovascular Invasion with Lymph Node Metastases in Prostate Cancer-Lateralization Concept

Jakub Karwacki et al. Cancers (Basel). .

Abstract

Background: Lymphovascular invasion (LVI) is a vital but often overlooked prognostic factor in prostate cancer. As debates on lymphadenectomy's overtreatment emerge, understanding LVI laterality gains importance. This study pioneers the investigation into PCa, aiming to uncover patterns that could influence tailored surgical strategies in the future.

Methods: Data from 96 patients with both LVI and lymph node invasion (LNI) were retrospectively analyzed. All participants underwent radical prostatectomy (RP) with modified-extended pelvic lymph node dissection (mePLND). All specimens underwent histopathological examination. The assessment of LVI was conducted separately for the right and left lobes of the prostate. Associations within subgroups were assessed using U-Mann-Whitney and Kruskal-Wallis tests, as well as Kendall's tau-b coefficient, yielding p-values and odds ratios (ORs).

Results: Out of the 96 patients, 61 (63.5%) exhibited exclusive left-sided lymphovascular invasion (LVI), 24 (25.0%) had exclusive right-sided LVI, and 11 (11.5%) showed bilateral LVI. Regarding nodal involvement, 23 patients (24.0%) had LNI solely on the left, 25 (26.0%) exclusively on the right, and 48 (50.0%) on both sides. A significant correlation was observed between lateralized LVI and lateralized LNI (p < 0.001), particularly in patients with right-sided LVI only. LN-positive patients with left-sided LVI tended to have higher pT stages (p = 0.047) and increased odds ratios (OR) of bilateral LNI (OR = 2.795; 95% confidence interval [CI]: 1.231-6.348) compared to those with exclusive right-sided LVI (OR = 0.692; 95% CI: 0.525-0.913).

Conclusions: Unilateral LVI correlates with ipsilateral LNI in PCa patients with positive LNs, notably in cases of exclusively right-sided LVI. Left-sided LVI associates with higher pT stages and a higher percentage of bilateral LNI cases.

Keywords: histopathological examination; lymph node invasion; lymphovascular invasion; nodal involvement lateralization; pelvic lymph node dissection; prostate cancer; radical prostatectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart illustrating the process of patient selection. pL0: negative lymphovascular invasion (LVI) in histopathological examination; pL1: positive LVI in histopathological examination; pN0: negative lymph node invasion (LNI) in histopathological examination; pN1: positive LNI in histopathological examination.
Figure 2
Figure 2
The visual illustration of patients’ distribution, categorizing them into unilateral left, unilateral right, and bilateral groups based on lymphovascular invasion (LVI) laterality. Yellow color represents the number of patients with positive lymph nodes only on the left side, red color represents patients with nodal involvement exclusively on the right side, and blue color represents patients with bilateral nodal invasion. n: number of patients; RL: LVI in the right lobe; LL: LVI in the left lobe.
Figure 3
Figure 3
The visual illustration of patients’ distribution, categorizing them into unilateral left, unilateral right, and bilateral groups based on nodal invasion laterality. Yellow color represents the number of patients with positive lymph nodes only on the left side, red color represents patients with nodal involvement exclusively on the right side, and blue color represents patients with bilateral nodal invasion. n: number of patients; RL: lymphovascular invasion (LVI) in the right lobe; LL: LVI in the left lobe.
Figure 4
Figure 4
The Marimekko chart depicting the proportional relationship between lymphovascular invasion and lymph node invasion. LVI: lateralization; LNI: lymph node invasion; n: number of patients.

References

    1. Antunes A.A., Srougi M., Dall’Oglio M.F., Crippa A., Paranhos M., Cury J., Nesrallah L.J., Leite K.R. Microvascular Invasion Is an Independent Prognostic Factor in Patients with Prostate Cancer Treated with Radical Prostatectomy. Int. Braz. J. Urol. 2006;32:668–675. doi: 10.1590/S1677-55382006000600007. - DOI - PubMed
    1. De La Taille A., Rubin M.A., Buttyan R., Olsson C.A., Bagiella E., Burchardt M., Wellisch O.M., Katz A.E. Is Microvascular Invasion on Radical Prostatectomy Specimens a Useful Predictor of PSA Recurrence for Prostate Cancer Patients? Eur. Urol. 2000;38:79–84. doi: 10.1159/000020256. - DOI - PubMed
    1. Herman C.M., Wilcox G.E., Kattan M.W., Scardino P.T., Wheeler T.M. Lymphovascular Invasion as a Predictor of Disease Progression in Prostate Cancer. Am. J. Surg. Pathol. 2000;24:859–863. doi: 10.1097/00000478-200006000-00012. - DOI - PubMed
    1. Shariat S.F., Khoddami S.M., Saboorian H., Koeneman K.S., Sagalowsky A.I., Cadeddu J.A., McConnell J.D., Holmes M.N., Roehrborn C.G. Lymphovascular Invasion Is a Pathological Feature of Biologically Aggressive Disease in Patients Treated with Radical Prostatectomy. J. Urol. 2004;171:1122–1127. doi: 10.1097/01.ju.0000113249.82533.28. - DOI - PubMed
    1. Loeb S., Roehl K.A., Yu X., Antenor J.A.V., Han M., Gashti S.N., Yang X.J., Catalona W.J. Lymphovascular Invasion in Radical Prostatectomy Specimens: Prediction of Adverse Pathologic Features and Biochemical Progression. Urology. 2006;68:99–103. doi: 10.1016/j.urology.2006.02.004. - DOI - PubMed